SHARECARE, INC. Net Change in Cash
SHARECARE, INC. reported Net Change in Cash of -$43.04 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-08-09
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$27.87M.
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$28.08M.
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$17.80M, a 325.76% decline year-over-year.
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $7.88M.
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$54.32M.
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$88.60M, a 135.65% decline from fiscal 2021.
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $248.50M.
- SHARECARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was -$1.07M, a 116.31% decline from fiscal 2019.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$43.04M 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | -$27.87M 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | -$54.32M 10-K · filed 2024-03-29 | |||
| 2023-09-30 | -$54.50M 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | -$38.35M 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | -$28.08M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$88.60M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$68.54M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$59.53M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$17.80M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $248.50M 10-K · filed 2024-03-29 | |||
| 2021-09-30 | $303.31M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $20.24M 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | $7.88M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$1.07M 10-K · filed 2023-03-31 | |||
| 2020-09-30 | -$494.00K 10-Q · filed 2021-11-10 | |||
| 2019-12-31 | $6.59M 10-K · filed 2022-03-31 |